MedPath
NMPA Approval

Ranitidine Hydrochloride Tablets

国药准字H37023034

March 31, 2021

国药准字H37023034

Drug Information

盐酸雷尼替丁片

片剂

0.15克(以雷尼替丁计)

化学药品

March 31, 2021

Company Information

Applicant Company

山东省平邑县经济开发区银花路西段(经济开发区002号)

Manufacturing Company

山东省临沂市临西十一路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁片 - NMPA 批准文号 | MedPath